Original Research
Published on 17 Jun 2021
Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.666600
- 16,982 views
- 77 citations
Type at least 3 characters
580 articles
Articles
Review
Published on 14 Jun 2021
Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.659577
- 17,235 views
- 35 citations
Original Research
Published on 11 Jun 2021
AGR3 Regulates Airway Epithelial Junctions in Patients with Frequent Exacerbations of COPD
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.669403
- 2,838 views
- 9 citations
Original Research
Published on 08 Jun 2021
Anti-Fibrotic Effects of Low Toxic Microcystin-RR on Bleomycin-Induced Pulmonary Fibrosis: A Comparison with Microcystin-LR
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.675907
- 3,505 views
- 10 citations
Review
Published on 07 Jun 2021
Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.664349
- 73,016 views
- 54 citations
Original Research
Published on 28 May 2021
Circulating Plasma miRNA and Clinical/Hemodynamic Characteristics Provide Additional Predictive Information About Acute Pulmonary Thromboembolism, Chronic Thromboembolic Pulmonary Hypertension and Idiopathic Pulmonary Hypertension
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.648769
- 5,284 views
- 12 citations
Original Research
Published on 14 May 2021
Enhanced Expression of Human Epididymis Protein 4 (HE4) Reflecting Pro-Inflammatory Status Is Regulated by CFTR in Cystic Fibrosis Bronchial Epithelial Cells
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.592184
- 3,621 views
- 10 citations
Original Research
Published on 04 May 2021
The Cholinergic Drug Pyridostigmine Alleviates Inflammation During LPS-Induced Acute Respiratory Distress Syndrome
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.624895
- 7,197 views
- 11 citations
Review
Published on 30 Apr 2021
Intermittent Hypoxic Preconditioning: A Potential New Powerful Strategy for COVID-19 Rehabilitation
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.643619
- 11,458 views
- 14 citations
Review
Published on 27 Apr 2021
Intensive Care and Treatment of Severe Guillain–Barré Syndrome
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.608130
- 68,323 views
- 45 citations
Review
Published on 27 Apr 2021
On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.662110
- 16,503 views
- 20 citations
Original Research
Published on 26 Apr 2021
Knockout of Formyl Peptide Receptor-1 Attenuates Cigarette Smoke–Induced Airway Inflammation in Mice
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.632225
- 2,650 views
- 10 citations
Original Research
Published on 26 Apr 2021
Breaching the Delivery Barrier: Chemical and Physical Airway Epithelium Disruption Strategies for Enhancing Lentiviral-Mediated Gene Therapy
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.669635
- 3,089 views
- 6 citations
Original Research
Published on 23 Apr 2021
The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.668902
- 4,997 views
- 4 citations
Original Research
Published on 23 Apr 2021
Leflunomide Induces Dose-Dependent Lung Injury in Mice via Stimulating Vimentin and NLRP3 Inflammasome Production
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.631216
- 4,750 views
- 6 citations
Mini Review
Published on 23 Apr 2021
Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.642822
- 8,474 views
- 46 citations